Preliminary results of biodistribution and dosimetric analysis of [68Ga]Ga-DOTAZOL: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases
- 15 March 2019
- journal article
- research article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 33 (6) , 404-413
Abstract
Pre-clinical studies with gallium-68 zoledronate ([68Ga]Ga-DOTAZOL) have proposed it to be a potent bisphosphonate for PET/CT diagnosis of bone diseases and diagnostic counterpart to [177Lu]Lu-DOTAZOL and [225Ac]Ac-DOTAZOL. This study aims to be the first human biodistribution and dosimetric analysis of [68Ga]Ga-DOTAZOL.Keywords
This publication has 37 references indexed in Scilit:
- Measured Human Dosimetry of68Ga-DOTATATEJournal of Nuclear Medicine, 2013
- Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate CancerClinical Nuclear Medicine, 2013
- THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka ExperienceTheranostics, 2012
- The relationship between the chemistry and biological activity of the bisphosphonatesBone, 2011
- Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis managementDrug, Healthcare and Patient Safety, 2010
- AbstractAnnals of the ICRP, 2008
- Bisphosphonates: Mode of Action and PharmacologyPediatrics, 2007
- Update: Establishing a Clinically Meaningful Predictive Model of Hematologic Toxicity in Nonmyeloablative Targeted Radiotherapy: Practical Aspects and Limitations of Red Marrow DosimetryCancer Biotherapy and Radiopharmaceuticals, 2005
- Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapyActa Oncologica, 2005
- Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including RasJournal of Bone and Mineral Research, 1998